Benzinga's Top Upgrades

Analysts at Cantor Fitzgerald upgraded Aetna Inc AET from Hold to Buy. The price target for Aetna has been raised from $100 to $140. Aetna shares closed at $117.75 on Thursday. Analysts at Cowen & Company upgraded FMC Corp FMC from Market Perform to Outperform. The price target for FMC has been lowered from $60 to $51. FMC shares closed at $38.79 on Thursday. Analysts at JP Morgan upgraded The Valspar Corp VAL from Neutral to Overweight. The price target for Valspar has been raised from $82 to $83. Valspar shares closed at $74.91 on Thursday. Credit Suisse upgraded Dillard's, Inc. DDS to Neutral. The price target for Dillard's has been lowered from $100 to $95. Dillard's shares closed at $92.30 on Thursday. Raymond James upgraded Goldman Sachs BDC Inc GSBD from Market Perform to Outperform. Goldman Sachs BDC shares closed at $20.22 on Thursday. Analysts at RBC Capital upgraded Core Laboratories N.V. CLB from Sector Perform to Outperform. The price target for Core Laboratories has been raised from $125 to $130. Core Laboratories shares closed at $108.74 on Thursday. UBS upgraded PPL Corp PPL from Neutral to Buy. The price target for PPL has been lowered from $34 to $33. PPL shares closed at $30.79 on Thursday.